Phentermine for weight loss in teens
Part of Hormones & metabolism clinical trials.
This study tests a medicine called phentermine to help teens ages 12 to 17 with obesity lose weight. It will check if the medicine is safe and works well for teenagers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 17 years old.
- You must have obesity (BMI at or above the 95th percentile for your age and sex, or a BMI of 30 or higher).
- Females who can get pregnant must agree to use effective birth control.
- You cannot have any heart problems, glaucoma, or be taking certain medicines (like MAO inhibitors, some antidepressants, or stimulants for ADHD).
- You cannot have diabetes, high blood pressure, or certain other medical conditions such as an eating disorder or a history of drug or nicotine use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what helps or drives weight changes in children and teens with obesity. You may be asked about growth and body changes to better understand why weight changes happen and how to manage them.
This study tests a combination of two medications, phentermine and topiramate, to see if they help young people with hypothalamic obesity lose weight safely. Hypothalamic obesity is rapid weight gain caused by injury to the hypothalamus, often from a brain tumor or its treatment.
This trial tests a combination pill (phentermine and topiramate) to help teens and young adults who are overweight after finishing cancer treatment. The goal is to improve metabolic health and manage weight in remission.
This trial tests a medication for children and teens with obesity or overweight who have not been able to lose enough weight with diet and exercise alone. It aims to see if a new treatment can help them safely lose weight and improve related health problems.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
This study tests a program to help young adults with a family history of obesity avoid gaining weight. It involves checking if certain health conditions or medications would make the program unsafe.
Hear when a new Childhood Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.